{
  "id": "nclex_ngn_cloze_mission_500_153_1771351381760",
  "questionType": "clozeDropdown",
  "itemBank": "Elite NCLEX-RN NGN Psychometrician & Content Scientist (Standard 2026)",
  "scoring": "+/-",
  "difficulty": "4",
  "caseId": "standalone_anaphylaxis_500",
  "question": "A nurse in an outpatient infusion clinic is caring for a 48-year-old client with severe psoriatic arthritis receiving their first infusion of a new biologic agent. Use the client data to complete the sentences below. \n\nThe nurse should first recognize that the client is exhibiting signs of [1]. This is primarily indicated by the [2]. The nurse's IMMEDIATE priority is to [3]. The nurse must then prepare to administer [4].",
  "tabs": [
    {
      "id": "nursesNotes",
      "label": "Nurses' Notes",
      "content": "1000: Client is a 48-year-old male with a history of hypertension and severe psoriatic arthritis, here for first dose of PsoriVantiv 300 mg IV. Client states, 'I'm excited to try this new medicine, the joint pain has been unbearable.' Client reports living in a rural area, a 2.5-hour drive from the clinic. Baseline assessment is within normal limits. IV access established, and infusion started as ordered.\n\n1015: Client uses the call light. Reports 'sudden, intense itching' on chest and back, and a 'lump in my throat.' Client appears anxious and is flushed. Skin is warm and diaphoretic."
    },
    {
      "id": "vitalSigns",
      "label": "Vital Signs",
      "content": [
        {
          "Time": "1000",
          "BP": "138/86 mmHg",
          "HR": "76 bpm",
          "RR": "16/min",
          "SpO2": "98% on room air",
          "Temp": "37.0째C (98.6째F)"
        },
        {
          "Time": "1017",
          "BP": "90/52 mmHg",
          "HR": "128 bpm",
          "RR": "28/min",
          "SpO2": "91% on room air",
          "Temp": "37.1째C (98.8째F)"
        }
      ]
    },
    {
      "id": "mar",
      "label": "MAR",
      "content": [
        {
          "Medication": "PsoriVantiv 300 mg in 250 mL 0.9% sodium chloride",
          "Route": "IV",
          "Frequency": "One-time dose",
          "Time": "1000",
          "Status": "Infusing"
        },
        {
          "Medication": "Lisinopril 10 mg",
          "Route": "PO",
          "Frequency": "Daily",
          "Time": "0900",
          "Status": "Given"
        },
        {
          "Medication": "Metoprolol Tartrate 50 mg",
          "Route": "PO",
          "Frequency": "BID",
          "Time": "1000",
          "Status": "Due"
        },
        {
          "Medication": "Acetaminophen 650 mg",
          "Route": "PO",
          "Frequency": "q6h PRN pain",
          "Time": "---",
          "Status": "Not given"
        }
      ]
    },
    {
      "id": "ecg",
      "label": "ECG",
      "content": "A 12-lead ECG was performed at 1018.\nInterpretation: Sinus tachycardia at a rate of 128 bpm. No acute ST-segment elevation or depression. No evidence of ischemia or infarction."
    }
  ],
  "dropdowns": [
    {
      "id": 1,
      "options": [
        "anaphylactic shock",
        "a vasovagal response",
        "septic shock"
      ]
    },
    {
      "id": 2,
      "options": [
        "acute onset of hypotension, tachycardia, and hypoxia",
        "client's report of anxiety and flushing",
        "normal ECG findings aside from tachycardia"
      ]
    },
    {
      "id": 3,
      "options": [
        "stop the PsoriVantiv infusion",
        "administer the scheduled metoprolol",
        "place the client in a high-Fowler's position"
      ]
    },
    {
      "id": 4,
      "options": [
        "intramuscular epinephrine",
        "an intravenous fluid bolus",
        "oral diphenhydramine"
      ]
    }
  ],
  "answerKey": [
    "anaphylactic shock",
    "acute onset of hypotension, tachycardia, and hypoxia",
    "stop the PsoriVantiv infusion",
    "intramuscular epinephrine"
  ],
  "answerBreakdown": {
    "1": {
      "correct": "anaphylactic shock",
      "rationales": {
        "anaphylactic shock": "Correct. Anaphylactic shock is a severe, life-threatening systemic hypersensitivity reaction characterized by rapid onset and potentially fatal consequences. It is triggered by an allergen (in this case, the new biologic agent PsoriVantiv) that causes widespread mast cell and basophil degranulation, releasing mediators like histamine, leukotrienes, and prostaglandins. These mediators lead to vasodilation, increased capillary permeability, bronchoconstriction, and smooth muscle contraction. The resulting hypotension, respiratory distress, and potential cardiovascular collapse require immediate intervention.",
        "a vasovagal response": "Incorrect. A vasovagal response is triggered by the vagus nerve, leading to bradycardia and hypotension due to decreased sympathetic tone and increased parasympathetic tone. It is often caused by emotional stress, pain, or prolonged standing. The client's presentation of tachycardia, flushing, and respiratory distress is inconsistent with a vasovagal response.",
        "septic shock": "Incorrect. Septic shock is a life-threatening condition caused by a dysregulated host response to infection. It involves widespread inflammation, vasodilation, and microvascular dysfunction. While hypotension and tachycardia can be present, the rapid onset of symptoms immediately following the infusion, along with the presence of itching and a lump in the throat, are more indicative of anaphylaxis."
      }
    },
    "2": {
      "correct": "acute onset of hypotension, tachycardia, and hypoxia",
      "rationales": {
        "acute onset of hypotension, tachycardia, and hypoxia": "Correct. The acute onset of hypotension (BP dropping from 138/86 mmHg to 90/52 mmHg), tachycardia (HR increasing from 76 bpm to 128 bpm), and hypoxia (SpO2 decreasing from 98% to 91%) are critical indicators of anaphylactic shock. The vasodilation caused by histamine and other mediators leads to a decrease in systemic vascular resistance and subsequent hypotension. The body attempts to compensate for the decreased blood pressure by increasing the heart rate. Bronchoconstriction and airway edema contribute to impaired gas exchange and hypoxia.",
        "client's report of anxiety and flushing": "Incorrect. While anxiety and flushing are common symptoms of anaphylaxis, they are subjective findings and not the primary indicators of shock. The objective vital sign changes provide more definitive evidence of the severity of the reaction.",
        "normal ECG findings aside from tachycardia": "Incorrect. While the ECG rules out acute cardiac ischemia, the sinus tachycardia is a compensatory mechanism in response to the hypotension. The ECG findings alone do not confirm the presence of anaphylactic shock."
      }
    },
    "3": {
      "correct": "stop the PsoriVantiv infusion",
      "rationales": {
        "stop the PsoriVantiv infusion": "Correct. The immediate priority in managing anaphylactic shock is to stop the administration of the causative agent (PsoriVantiv) to prevent further exposure to the allergen and minimize the severity of the reaction. Continuing the infusion would exacerbate the release of inflammatory mediators and worsen the client's condition.",
        "administer the scheduled metoprolol": "Incorrect. Administering metoprolol, a beta-blocker, is contraindicated in anaphylactic shock. Beta-blockers can worsen hypotension and bronchoconstriction, and they can also interfere with the effectiveness of epinephrine, the first-line treatment for anaphylaxis.",
        "place the client in a high-Fowler's position": "Incorrect. Placing the client in a high-Fowler's position is not appropriate in this situation. Hypotension is a primary concern, and this position can exacerbate it by promoting venous pooling in the lower extremities. The client should be placed in a supine position with legs elevated to promote venous return to the heart."
      }
    },
    "4": {
      "correct": "intramuscular epinephrine",
      "rationales": {
        "intramuscular epinephrine": "Correct. Epinephrine is the first-line medication for anaphylactic shock. It is an alpha- and beta-adrenergic agonist that works by reversing the pathophysiologic effects of anaphylaxis. Alpha-adrenergic effects cause vasoconstriction, which increases blood pressure and reduces mucosal edema. Beta-adrenergic effects cause bronchodilation, which improves breathing. Epinephrine also inhibits the release of inflammatory mediators from mast cells and basophils. Intramuscular administration provides rapid absorption and onset of action.",
        "an intravenous fluid bolus": "Incorrect. While intravenous fluids are important for addressing the vasodilation and increased capillary permeability associated with anaphylaxis, they are a secondary intervention. Epinephrine is the priority to reverse the life-threatening symptoms.",
        "oral diphenhydramine": "Incorrect. Diphenhydramine is an antihistamine that can help relieve itching and hives, but it does not address the life-threatening symptoms of anaphylaxis, such as hypotension and bronchoconstriction. It is a secondary medication that can be administered after epinephrine."
      }
    }
  },
  "clinicalPearls": [
    "Anaphylaxis is a medical emergency requiring prompt recognition and treatment.",
    "Early signs of anaphylaxis can include itching, flushing, urticaria, and angioedema.",
    "Hypotension, tachycardia, and respiratory distress are critical indicators of anaphylactic shock.",
    "Epinephrine is the first-line treatment for anaphylaxis and should be administered immediately.",
    "Beta-blockers are contraindicated in anaphylaxis.",
    "Always stop the offending agent immediately when anaphylaxis is suspected during an infusion.",
    "Monitor the client closely for recurrence of symptoms after initial treatment."
  ],
  "sbar": {
    "situation": "48-year-old male receiving first infusion of PsoriVantiv for severe psoriatic arthritis.",
    "background": "History of hypertension. At 1015, 15 minutes after infusion started, reports sudden itching, lump in throat, anxiety, and flushing.",
    "assessment": "At 1017, BP 90/52 mmHg, HR 128 bpm, RR 28/min, SpO2 91% on room air. ECG at 1018 shows sinus tachycardia.",
    "recommendation": "Suspect anaphylactic shock. Stop PsoriVantiv infusion immediately. Prepare to administer intramuscular epinephrine stat."
  },
  "sentinelStatus": "healed_v2026_v8"
}